Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 297
1.
Biochem Pharmacol ; 197: 114839, 2022 03.
Article En | MEDLINE | ID: mdl-34774846

Autophagy is being increasingly recognized as an important regulator of intestinal ischemia-reperfusion(I/R)injury, but its exact role is still debated. Emerging evidence suggests that miR-146a-5p is involved in the initiation and development of I/R injury, but its role in intestinal I/R injury remains unclear. The present study generated an intestinal I/R mouse model and an oxygen glucose deprivation/reoxygenation (OGD/R) Caco-2 cell model and found that autophagy was increased and contributed to the intestinal injury and cell death induced by I/R and OGD/R. In addition, in both I/R and OGD/R models, the miR-146a-5p expression level was decreased and accompanied by an increase in TXNIP expression. By transfecting cells with an miR-146a-5p inhibitor or mimic, we observed that miR-146a-5p inhibits autophagy during OGD/R by targeting TXNIP; this was confirmed by the dual luciferase reporter gene assay. Additionally, through overexpression and knockdown cell lines, we established that TXNIP regulates autophagy during intestinal I/R via the PRKAA/mTOR pathway. The interaction between TXNIP and p-PRKAA was verified by immunofluorescence co-localization and immunoprecipitation assays. Moreover, we confirmed that TXNIP is indispensable for miR-146a-5p-mediated cell protection. Finally, we observed that miR-146a-5p overexpression inhibits autophagy and attenuates intestinal I/R injury via the PRKAA/mTOR pathway by targeting TXNIP in vivo. In conclusion, this study highlights the role of miR-146a-5p in regulating autophagy by targeting TXNIP, suggesting that miR-146a-5p may be a novel drug target for intestinal I/R therapy.


AMP-Activated Protein Kinases/metabolism , Carrier Proteins/biosynthesis , Intestines/metabolism , MicroRNAs/biosynthesis , Reperfusion Injury/metabolism , TOR Serine-Threonine Kinases/metabolism , Thioredoxins/biosynthesis , Animals , Autophagy/physiology , Caco-2 Cells , Humans , Intestines/blood supply , Intestines/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Reperfusion Injury/pathology , Reperfusion Injury/prevention & control , Signal Transduction/physiology
2.
Int J Mol Sci ; 22(19)2021 Sep 27.
Article En | MEDLINE | ID: mdl-34638735

In Arabidopsis seeds, ROS have been shown to be enabling actors of cellular signaling pathways promoting germination, but their accumulation under stress conditions or during aging leads to a decrease in the ability to germinate. Previous biochemical work revealed that a specific class of plastid thioredoxins (Trxs), the y-type Trxs, can fulfill antioxidant functions. Among the ten plastidial Trx isoforms identified in Arabidopsis, Trx y1 mRNA is the most abundant in dry seeds. We hypothesized that Trx y1 and Trx y2 would play an important role in seed physiology as antioxidants. Using reverse genetics, we found important changes in the corresponding Arabidopsis mutant seeds. They display remarkable traits such as increased longevity and higher and faster germination in conditions of reduced water availability or oxidative stress. These phenotypes suggest that Trxs y do not play an antioxidant role in seeds, as further evidenced by no changes in global ROS contents and protein redox status found in the corresponding mutant seeds. Instead, we provide evidence that marker genes of ABA and GAs pathways are perturbed in mutant seeds, together with their sensitivity to specific hormone inhibitors. Altogether, our results suggest that Trxs y function in Arabidopsis seeds is not linked to their previously identified antioxidant roles and reveal a new role for plastid Trxs linked to hormone regulation.


Arabidopsis Proteins/biosynthesis , Arabidopsis/metabolism , Gene Expression Regulation, Plant , Plant Growth Regulators/metabolism , Plastids/metabolism , Seeds/metabolism , Thioredoxins/biosynthesis , Arabidopsis/genetics , Arabidopsis Proteins/genetics , Germination , Plant Growth Regulators/genetics , Plastids/genetics , Seeds/growth & development , Thioredoxins/genetics
3.
J Mol Biol ; 433(24): 167321, 2021 12 03.
Article En | MEDLINE | ID: mdl-34687715

Obligate symbionts typically exhibit high evolutionary rates. Consequently, their proteins may differ considerably from their modern and ancestral homologs in terms of both sequence and properties, thus providing excellent models to study protein evolution. Also, obligate symbionts are challenging to culture in the lab and proteins from uncultured organisms must be produced in heterologous hosts using recombinant DNA technology. Obligate symbionts thus replicate a fundamental scenario of metagenomics studies aimed at the functional characterization and biotechnological exploitation of proteins from the bacteria in soil. Here, we use the thioredoxin from Candidatus Photodesmus katoptron, an uncultured symbiont of flashlight fish, to explore evolutionary and engineering aspects of protein folding in heterologous hosts. The symbiont protein is a standard thioredoxin in terms of 3D-structure, stability and redox activity. However, its folding outside the original host is severely impaired, as shown by a very slow refolding in vitro and an inefficient expression in E. coli that leads mostly to insoluble protein. By contrast, resurrected Precambrian thioredoxins express efficiently in E. coli, plausibly reflecting an ancient adaptation to unassisted folding. We have used a statistical-mechanical model of the folding landscape to guide back-to-ancestor engineering of the symbiont protein. Remarkably, we find that the efficiency of heterologous expression correlates with the in vitro (i.e., unassisted) folding rate and that the ancestral expression efficiency can be achieved with only 1-2 back-to-ancestor replacements. These results demonstrate a minimal-perturbation, sequence-engineering approach to rescue inefficient heterologous expression which may potentially be useful in metagenomics efforts targeting recent adaptations.


Bacterial Proteins/biosynthesis , Fishes/microbiology , Protein Folding , Recombinant Proteins/biosynthesis , Vibrionaceae/metabolism , Animals , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Escherichia coli/metabolism , Metagenomics , Protein Engineering , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Symbiosis , Thioredoxins/biosynthesis , Thioredoxins/chemistry , Vibrionaceae/genetics
4.
J Diabetes Complications ; 35(12): 108050, 2021 12.
Article En | MEDLINE | ID: mdl-34600826

AIMS: In the present study, we investigated the effect of carbohydrate responsive element binding protein (ChREBP) on the TXNIP/oxidative stress and apoptosis in diabetic nephropathy. METHODS: ChREBP-/- mice (8-week old) were produced using the CRISPR/Cas9 gene editing approach. Diabetes was induced in C57BL/6 mice with streptozotocin. HK-2 cells was transfected with plasmid containing either ChREBP shRNA or TXNIP siRNA. RESULTS: Renal expression of ChREBP and thioredoxin-interacting protein (TXNIP) was increased in patients with type 2 diabetes mellitus (T2DM) and diabetic mice. ChREBP deficiency improved renal function, apoptosis as well as endoplasmic reticulum (ER) stress in diabetic mice. In addition, ChREBP deficiency prevented expression levels of TXNIP and NADPH oxidase 4 (Nox4), 8-hydroxydeoxyguanosine (8-OHdG) and heme oxygenase-1 (HO-1) in diabetic kidneys. The increased urinary 8-OHdG level induced by diabetes was also attenuated in ChREBP deficiency mice. Similarly, HG was shown to induce ChREBP expression and nuclear translocation in HK-2 cells. HG-induced apoptosis was inhibited by transfection of ChREBP shRNA plasmid. Moreover, we found that knockdown of ChREBP suppressed HG-induced TXNIP and Nox4 expression, reactive oxygen species (ROS) generation and ER stress in HK-2 cells. Furthermore, TXNIP knockdown effectively abrogated HG-induced apoptosis in HK-2 cells. CONCLUSIONS: These results suggest that ChREBP deficiency prevents diabetes-induced apoptosis via inhibiting oxidative stress and ER stress, highlighting ChREBP as a potential therapy target for diabetic nephropathy.


Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Carrier Proteins , Diabetes Mellitus, Type 2 , Diabetic Nephropathies , Thioredoxins , Animals , Apoptosis/physiology , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/biosynthesis , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/deficiency , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/genetics , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/metabolism , Blood Glucose/analysis , Carrier Proteins/biosynthesis , Cells, Cultured , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/genetics , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/metabolism , Diabetic Nephropathies/etiology , Diabetic Nephropathies/genetics , Diabetic Nephropathies/metabolism , Disease Models, Animal , Endoplasmic Reticulum Stress/physiology , Gene Editing , Humans , Hyperglycemia/complications , Hyperglycemia/metabolism , Kidney/cytology , Kidney/metabolism , Kidney/pathology , Mice , Mice, Inbred C57BL , Oxidative Stress/physiology , Thioredoxins/biosynthesis
5.
Neurochem Res ; 46(11): 3035-3049, 2021 Nov.
Article En | MEDLINE | ID: mdl-34327632

Epigallocatechin gallate (EGCG) is one of polyphenol that is abundant in green tea. It has anti-oxidative activity and exerts neuroprotective effects in ischemic brain damage. Ischemic conditions induce oxidative stress and result in cell death. Thioredoxin is a small redox protein that plays an important role in the regulation of oxidation and reduction. This study was designed to investigate the regulation of thioredoxin by EGCG in ischemic brain damage. Middle cerebral artery occlusion (MCAO) was performed to induce focal cerebral ischemia in male Sprague-Dawley rats. The EGCG (50 mg/kg) or was administered before MCAO surgical operation. Neurological behavior test, reactive oxygen species (ROS), and lipid peroxidation (LPO) measurement were performed 24 h after MCAO. The cerebral cortex was isolated for further experiments. EGCG alleviated MCAO-induced neurological deficits and increases in ROS and LPO levels. EGCG also ameliorated the decrease in thioredoxin expression by MCAO. This finding was confirmed using various techniques such as Western blot analysis, reverse transcription PCR, and immunofluorescence staining. Results of immunoprecipitation showed that MCAO decreases the interaction between apoptosis signal-regulating kinase 1 (ASK1) and thioredoxin, while EGCG treatment attenuates this decrease. EGCG also attenuated decrease of cell viability and thioredoxin expression in glutamate-exposed neuron in a dose-dependent manner. It alleviated the increase of caspase-3 by glutamate exposure. However, this effect of EGCG on caspase-3 change was weakened in thioredoxin siRNA-transfected neurons. These findings suggest that EGCG exerts a neuroprotective effect by regulating thioredoxin expression and modulating ASK1 and thioredoxin binding in ischemic brain damage.


Brain Ischemia/metabolism , Catechin/analogs & derivatives , Glutamic Acid/toxicity , Neurons/metabolism , Neuroprotective Agents/therapeutic use , Thioredoxins/biosynthesis , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Brain Ischemia/drug therapy , Catechin/pharmacology , Catechin/therapeutic use , Cell Line, Transformed , Down-Regulation/drug effects , Down-Regulation/physiology , Male , Mice , Neurons/drug effects , Neuroprotective Agents/pharmacology , Rats , Rats, Sprague-Dawley
6.
Neurobiol Dis ; 156: 105399, 2021 08.
Article En | MEDLINE | ID: mdl-34029695

Immune system hypersensitivity is believed to contribute to mental frailty in the elderly. Solid evidence indicates NOD-like receptor pyrin domain containing-3 (NLRP3)-inflammasome activation intimately connects aging-associated chronic inflammation (inflammaging) to senile cognitive decline. Thioredoxin interacting protein (TXNIP), an inducible protein involved in oxidative stress, is essential for NLRP3 inflammasome activity. This study aims to find whether TXNIP/NLRP3 inflammasome pathway is involved in senile dementia. According to our studies on sex-matched mice, TXNIP was significantly upregulated in aged animals, paralleled by the NLRP3-inflammasome over-activity leading to enhanced caspase-1 cleavage and IL-1ß maturation, in both sexes. This was closely associated with depletion of the anti-aging and cognition enhancing protein klotho, in aged males. Txnip knockout reversed age-related NLRP3-hyperactivity and enhanced thioredoxin (TRX) levels. Further, TXNIP inhibition along with verapamil replicated TXNIP/NLRP3-inflammasome downregulation in aged animals, with FOXO-1 and mTOR upregulation. These alterations concurred with substantial improvements in both cognitive and sensorimotor abilities. Together, these findings substantiate the pivotal role of TXNIP to drive inflammaging in parallel with klotho depletion and functional decline, and delineate thioredoxin system as a potential target to decelerate senile dementia.


Aging/metabolism , Brain/metabolism , Carrier Proteins/biosynthesis , Inflammation Mediators/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein/biosynthesis , Thioredoxins/biosynthesis , Aging/genetics , Aging/pathology , Animals , Brain/pathology , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/genetics , Female , Inflammation Mediators/antagonists & inhibitors , Male , Maze Learning/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , NLR Family, Pyrin Domain-Containing 3 Protein/antagonists & inhibitors , NLR Family, Pyrin Domain-Containing 3 Protein/genetics , Oxidative Stress/physiology , Thioredoxins/antagonists & inhibitors , Thioredoxins/genetics
7.
J Clin Invest ; 131(5)2021 03 01.
Article En | MEDLINE | ID: mdl-33465051

Renal fibrosis, a common pathological manifestation of virtually all types of chronic kidney disease (CKD), often results in diffuse kidney scarring and predisposes to end-stage renal disease. Currently, there is no effective therapy against renal fibrosis. Recently, our laboratory identified an ER-resident protein, thioredoxin domain containing 5 (TXNDC5), as a critical mediator of cardiac fibrosis. Transcriptome analyses of renal biopsy specimens from patients with CKD revealed marked TXNDC5 upregulation in fibrotic kidneys, suggesting a potential role of TXNDC5 in renal fibrosis. Employing multiple fluorescence reporter mouse lines, we showed that TXNDC5 was specifically upregulated in collagen-secreting fibroblasts in fibrotic mouse kidneys. In addition, we showed that TXNDC5 was required for TGF-ß1-induced fibrogenic responses in human kidney fibroblasts (HKFs), whereas TXNDC5 overexpression was sufficient to promote HKF activation, proliferation, and collagen production. Mechanistically, we showed that TXNDC5, transcriptionally controlled by the ATF6-dependent ER stress pathway, mediated its profibrogenic effects by enforcing TGF-ß signaling activity through posttranslational stabilization and upregulation of type I TGF-ß receptor in kidney fibroblasts. Using a tamoxifen-inducible, fibroblast-specific Txndc5 knockout mouse line, we demonstrated that deletion of Txndc5 in kidney fibroblasts mitigated the progression of established kidney fibrosis, suggesting the therapeutic potential of TXNDC5 targeting for renal fibrosis and CKD.


Fibroblasts/metabolism , Kidney Diseases/metabolism , Kidney/metabolism , Signal Transduction , Thioredoxins/biosynthesis , Transforming Growth Factor beta1/metabolism , Activating Transcription Factor 6/genetics , Activating Transcription Factor 6/metabolism , Animals , Cell Line , Endoplasmic Reticulum Stress/genetics , Fibroblasts/pathology , Fibrosis , Kidney/pathology , Kidney Diseases/genetics , Kidney Diseases/pathology , Mice , Mice, Knockout , Thioredoxins/genetics , Transforming Growth Factor beta1/genetics , Up-Regulation
8.
J Biochem Mol Toxicol ; 35(4): e22704, 2021 Apr.
Article En | MEDLINE | ID: mdl-33393188

In the present study, we demonstrate the coaction of thioredoxin and glutathione (GSH) systems in mouse liver against iron overload-induced oxidative stress (OS). Mice were injected intraperitoneally with an iron dextran solution twice a week for 3 weeks. Iron accumulation in mouse liver was demonstrated spectroscopically. To confirm the iron overload model in the liver, the increased gene expression levels of hepcidin (Hamp), ferroportin (Fpn1), and ferritin (Fth1), which regulate iron trafficking, were observed by a quantitative polymerase chain reaction. In the case of iron overload, the GSH level and the reduced glutathione/oxidized glutathione ratio, which represents a marker of OS, decreased significantly. An increase in the malondialdehyde level, one of the final products of the lipid peroxidation process, was observed. The gene expression of the thioredoxin system, including thioredoxin (Trx1) and thioredoxin reductase (TrxR1), was examined. Though TrxR1 expression decreased, no changes were observed in Trx1. The enzyme activity and semiquantitative protein expression of TRXR1 increased. The activity of GSH reductase and GSH peroxidase increased in the iron overload group. The gene and protein expressions of thioredoxininteracting protein, which is an indicator of the commitment of the cell to apoptosis, were elevated significantly. The increased protein expression of Bcl-2-related X protein and CASPASE-3, which is an indicator of apoptosis, increased significantly. In conclusion, excess iron accumulation in mouse liver tissue causes OS, which affects the redox state of the thioredoxin and GSH systems, inducing cell apoptosis and also ferroptosis due to increased lipid peroxidation and the depletion of GSH level.


Glutathione/metabolism , Iron Overload/metabolism , Liver/metabolism , Oxidative Stress , Thioredoxins/biosynthesis , Animals , Cation Transport Proteins/biosynthesis , Ferritins/biosynthesis , Gene Expression Regulation , Hepcidins/biosynthesis , Iron Overload/pathology , Liver/pathology , Male , Mice , Mice, Inbred BALB C , Oxidoreductases/biosynthesis
9.
Inflammation ; 44(1): 217-228, 2021 Feb.
Article En | MEDLINE | ID: mdl-32892306

Sepsis-induced acute kidney injury (SAKI) is a common complication of hospitalized patients, often leading to unacceptable mortality. Limited effective treatment or diagnosis biomarkers are available and the underlying mechanism remains unclear. The miR-30c-5p is considered as a critical mediator of kidney diseases and aberrantly decreased in patients with SAKI, while the mechanism is still unclear. For this purpose, the role of miR-30c-5p in SAKI has been investigated in this study. Here, we first confirmed that miR-30c-5p expression decreased in our septic models and was associated with the activation of NLRP3/caspase-1-mediated pyroptosis. Overexpression of miR-30c-5p alleviated the kidney injury via suppressing HK-2 cell pyroptosis. Furthermore, we identified that TXNIP was a direct target of miR-30c-5p. Upregulation of miR-30c-5p repressed the expression of TXNIP, which inhibited NLRP3, ASC, and caspase-1 expression, as well as secretion of inflammatory cytokines. In conclusion, our data suggested that miR-30c-5p negatively controlled the NLRP3 signal pathway-related pyroptosis and sepsis-induced injury via TXNIP, indicating that this axis might be a positive therapeutic target for the patient with SAKI.


Acute Kidney Injury/metabolism , Carrier Proteins/biosynthesis , MicroRNAs/biosynthesis , Pyroptosis/physiology , Sepsis/metabolism , Thioredoxins/biosynthesis , Acute Kidney Injury/prevention & control , Animals , Carrier Proteins/antagonists & inhibitors , Cell Line , HEK293 Cells , Humans , Mice , Mice, Inbred C57BL , Sepsis/prevention & control , Thioredoxins/antagonists & inhibitors
10.
Int J Mol Sci ; 21(19)2020 Sep 23.
Article En | MEDLINE | ID: mdl-32977624

Pathological remodeling is the main detrimental complication after myocardial infarction (MI). Overproduction of reactive oxygen species (ROS) in infarcted myocardium may contribute to this process. Adequate exercise training after MI may reduce oxidative stress-induced cardiac tissue damage and remodeling. SET and MYND domain containing 1 (Smyd1) is a muscle-specific histone methyltransferase which is upregulated by resistance training, may strengthen sarcomere assembly and myofiber folding, and may promote skeletal muscles growth and hypertrophy. However, it remains elusive if Smyd1 has similar functions in post-MI cardiac muscle and participates in exercise-induced cardioprotection. Accordingly, we investigated the effects of interval treadmill exercise on cardiac function, ROS generation, Smyd1 expression, and sarcomere assembly of F-actin in normal and infarcted hearts. Adult male rats were randomly divided into five groups (n = 10/group): control (C), exercise alone (EX), sham-operated (S), MI induced by permanent ligation of left anterior descending coronary artery (MI), and MI with interval exercise training (MI + EX). Exercise training significantly improved post-MI cardiac function and sarcomere assembly of F-actin. The cardioprotective effects were associated with increased Smyd1, Trx1, cTnI, and α-actinin expression as well as upregulated ratio of phosphorylated AMP-activated protein kinase (AMPK)/AMPK, whereas Hsp90, MuRF1, brain natriuretic peptide (BNP) expression, ROS generation, and myocardial fibrosis were attenuated. The improved post-MI cardiac function was associated with increased Smyd1 expression. In cultured H9C2 cardiomyoblasts, in vitro treatment with H2O2 (50 µmol/L) or AMP-activated protein kinase (AMPK) agonist (AICAR, 1 mmol/L) or their combination for 4 h simulated the effects of exercise on levels of ROS and Smyd1. In conclusion, we demonstrated a novel role of Smyd1 in association with post-MI exercise-induced cardioprotection. The moderate level of ROS-induced upregulation of Smyd1 may be an important target for modulating post-MI cardiac function and remodeling.


DNA-Binding Proteins/biosynthesis , Gene Expression Regulation, Developmental , Myocardial Infarction , Physical Conditioning, Animal , Ventricular Remodeling , Animals , Male , Myocardial Infarction/enzymology , Myocardial Infarction/pathology , Myocardial Infarction/prevention & control , Rats , Rats, Sprague-Dawley , Thioredoxins/biosynthesis
11.
Protein Expr Purif ; 175: 105708, 2020 11.
Article En | MEDLINE | ID: mdl-32738438

Enzymes involved in ß-glucan breakdown in plants include endoglucanases, exoglucanases and ß-glucosidases. Glycoside hydrolase family 3 (GH3) exoglucanases from barley and maize and a few plant GH3 ß-glucosidases have been characterized, but none from rice. A few of these enzymes have been expressed in recombinant yeast and plant systems, but bacterial expression of plant GH3 enzymes has not been successful. We expressed the rice GH3 exoglucanase OsExo2 in Escherichia coli as a thioredoxin fusion protein, while other active plant GH3 enzymes could not be produced in this system. The protein was purified over 2000-fold in three chromatographic steps. The enzyme hydrolyzed ß-1,3- and ß-1,4-linked oligosaccharides and polysaccharides, consistent with a role in cell wall remodeling. Of the oligosaccharides tested, it had highest catalytic efficiency toward laminaritriose, (apparent kcat/Km = 37.7 mM-1s-1). Among polysaccharides, OsExoII hydrolyzed barley mixed ß-glucan and laminarin with similar efficiencies (apparent kcat/Km = 3.7 and 3.4 mL mg-1 s-1, respectively), but achieved its highest apparent kcat with lichenan (2.9 s-1). OsExoII was found to be stimulated by ethylene glycol, which increased the apparent kcat and decreased the Km and was transglycosylated. These results imply that E. coli expression may be successful for certain plant GH3 enzymes and OsExoII may be a useful enzyme for application to glycoside production.


Cellulose 1,4-beta-Cellobiosidase , Oryza/genetics , Plant Proteins , Recombinant Fusion Proteins , Thioredoxins , Catalysis , Cellulose 1,4-beta-Cellobiosidase/biosynthesis , Cellulose 1,4-beta-Cellobiosidase/chemistry , Cellulose 1,4-beta-Cellobiosidase/genetics , Cellulose 1,4-beta-Cellobiosidase/isolation & purification , Escherichia coli/genetics , Escherichia coli/metabolism , Oligosaccharides/chemistry , Oryza/enzymology , Plant Proteins/biosynthesis , Plant Proteins/chemistry , Plant Proteins/genetics , Plant Proteins/isolation & purification , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/isolation & purification , Thioredoxins/biosynthesis , Thioredoxins/chemistry , Thioredoxins/genetics , Thioredoxins/isolation & purification
12.
Medicine (Baltimore) ; 99(21): e20294, 2020 May 22.
Article En | MEDLINE | ID: mdl-32481311

BACKGROUND: The aim of this study is to explore the effect of grelin on TRX expression (TRXE) in chronic heart failure tissue (CHFT). METHODS: We will search electronic databases from inception to the March 1, 2020 in MEDLINE, EMBASE, Cochrane Library, CINAHL, PEDro, the Allied and Complementary Medicine Database, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure. We will not apply any limitations to the language and publication status. Any randomized controlled trials (RCTs) that studied the effect of grelin on TRXE in CHFT will be included. Study quality will be checked by Cochrane risk of bias and evidence quality will be appraised by Grading of Recommendations Assessment Development and Evaluation. All extracted data will be analyzed by RevMan 5.3 Software. RESULTS: This study will summarize the present RCTs to assess the effect of grelin on TRXE in CHFT. CONCLUSION: The results of this study will provide conclusive evidence of the effect of grelin on TRXE in CHFT. SYSTEMATIC REVIEW REGISTRATION: INPLASY202040078.


Drugs, Chinese Herbal/pharmacology , Gene Expression Regulation/drug effects , Heart Failure/therapy , Medicine, Chinese Traditional/methods , Thioredoxins/genetics , DNA/genetics , Heart Failure/genetics , Heart Failure/metabolism , Humans , Thioredoxins/biosynthesis , Meta-Analysis as Topic
13.
Protein Pept Lett ; 27(10): 1038-1045, 2020.
Article En | MEDLINE | ID: mdl-32242774

BACKGROUND: Combined maneb (MB) and paraquat (PQ), two widely used pesticides, increases oxidative stress leading to Parkinsonism. Xenobiotic metabolizing enzymes, cytochrome P450 (CYP) 2D6 and its mouse ortholog Cyp2d22 protect against Parkinsonism. Resveratrol, an antioxidant, restores antioxidant defense system through the activation of nuclear factor erythroid 2- related factor 2 (Nrf2). However, a crosstalk between Cyp2d22/CYP2D6-mediated protection and resveratrol-induced Nrf2 activation leading to neuroprotection is not yet elucidated. OBJECTIVE: The study aimed to decipher the effect of resveratrol on Nrf2 activation and expression of its downstream mediators, nicotinamide adenine dinucleotide phosphate quinone oxidoreductase 1 (NQO1) and thioredoxin 1 (Trx1) along with Cyp2d22/CYP2D6 activity in combined MB and PQ mouse model of Parkinsonism and differentiated neuroblastoma cells. RESULTS: MB and PQ reduced the dopamine content (mouse) and Cyp2d22/CYP2D6 activity (mouse/neuroblastoma cells) and increased the nuclear translocation of Nrf2 and expression of NQO1 and Trx1 (both). Resveratrol ameliorated pesticides-induced changes in dopamine content and Cyp2d22/CYP2D6 activity. It was found to promote nuclear translocation of Nrf2 and expression of NQO1 and Trx1 proteins. Since Cyp2d22/CYP2D6 inhibitor (ketoconazole/quinidine) per se reduced Cyp2d22/CYP2D6 activity and dopamine content, it was found to substantially increase the pesticides-induced reduction in Cyp2d22/CYP2D6 activity and dopamine content. Inhibitors normalized the pesticides induced changes in Nrf2 translocation and NQO1 and Trx1 levels in pesticides treated groups. CONCLUSION: The results suggest that resveratrol promotes the catalytic activity of xenobiotic metabolizing enzyme, Cyp2d22/CYP2D6, which partially contributes to Nrf2 activation in pesticides- induced Parkinsonism.


Antioxidants/metabolism , Cytochrome P450 Family 2/biosynthesis , Gene Expression Regulation, Enzymologic/drug effects , NF-E2-Related Factor 2/metabolism , Neuroprotection/drug effects , Parkinson Disease, Secondary , Pesticides/toxicity , Resveratrol/pharmacology , Animals , Cell Line, Tumor , Male , Mice , NAD(P)H Dehydrogenase (Quinone) , Parkinson Disease, Secondary/chemically induced , Parkinson Disease, Secondary/metabolism , Parkinson Disease, Secondary/prevention & control , Thioredoxins/biosynthesis
14.
J Alzheimers Dis ; 72(1): 139-150, 2019.
Article En | MEDLINE | ID: mdl-31561358

Oxidative stress has been hypothesized to play a role in the pathophysiology of Alzheimer's disease (AD). Previously, we found that total nitrosylated protein levels were increased in the brain of amyloid-ß protein precursor (AßPP) and presenilin 1 (PS1) double transgenic mice, an animal model for AD, suggesting that cysteine oxidative protein modification may contribute to this disease. Thioredoxin (Trx) is a major oxidoreductase that can reverse cysteine oxidative modifications such as sulfenylation and nitrosylation, and inhibit oxidative stress. Thioredoxin-interacting protein (Txnip) is an endogenous Trx inhibitor. To understand the involvement of Trx and Txnip in AD development, we investigated Trx and Txnip in the brain of AßPP/PS1 mice. Using immunoblotting analysis, we found that although Trx protein levels were not changed, Txnip protein levels were significantly increased in hippocampus and frontal cortex of 9- and 12-month-old AßPP/PS1 mice when compared to wild-type mice. Txnip protein levels were also increased by amyloid-ß treatment in primary cultured mouse cerebral cortical neurons and HT22 mouse hippocampal cells. Using biotin switch and dimedone conjugation methods, we found that amyloid-ß treatment increased protein nitrosylation and sulfenylation in HT22 cells. We also found that downregulation of Txnip, using CRISPR/Cas9 method in HT22 cells, attenuated amyloid-ß-induced protein nitrosylation and sulfenylation. Our findings suggest that amyloid-ß may increase Txnip levels, subsequently inhibiting Trx reducing capability and enhancing protein cysteine oxidative modification. Our findings also indicate that Txnip may be a potential target for the treatment of AD.


Amyloid beta-Peptides/toxicity , Amyloid beta-Protein Precursor/genetics , Brain/metabolism , Carrier Proteins/biosynthesis , Carrier Proteins/genetics , Peptide Fragments/toxicity , Presenilin-1/genetics , Thioredoxins/biosynthesis , Thioredoxins/genetics , Age Factors , Animals , Brain/drug effects , Cell Line , Cells, Cultured , HEK293 Cells , Humans , Mice , Mice, Transgenic , Neurons/drug effects , Neurons/metabolism , Up-Regulation/drug effects , Up-Regulation/physiology
15.
PLoS One ; 14(7): e0218505, 2019.
Article En | MEDLINE | ID: mdl-31265467

The Gram-negative pathogen, Acinetobacter baumannii has emerged as a global nosocomial health threat affecting the majority of hospitals in the U.S. and abroad. The redox protein thioredoxin has been shown to play several roles in modulation of cellular functions affecting various virulence factors in Gram-negative pathogens. This study aims to explore the role of thioredoxin-A protein (TrxA) in A. baumannii virulence. We determined that deletion of the TrxA gene did not significantly affect resistance to environmental stressors such as temperature, salt, and pH. However, TrxA was critical for survival in the presence of elevated levels of hydrogen peroxide. Lack of TrxA was associated with decreased expression of type IV pili related genes and an inability to undergo normal twitching motility. Interestingly, the TrxA-null mutant was able to form biofilms better than the wildtype (WT) and was observed to be significantly less virulent than the WT in a pulmonary infection model. These results are supportive of thioredoxin playing a key role in A. baumannii virulence.


Acinetobacter Infections , Acinetobacter baumannii , Bacterial Proteins , Fimbriae, Bacterial , Thioredoxins , Virulence Factors , Acinetobacter Infections/genetics , Acinetobacter Infections/metabolism , Acinetobacter baumannii/genetics , Acinetobacter baumannii/metabolism , Acinetobacter baumannii/pathogenicity , Animals , Bacterial Proteins/biosynthesis , Bacterial Proteins/genetics , Female , Fimbriae, Bacterial/genetics , Fimbriae, Bacterial/metabolism , Gene Expression Regulation, Bacterial , Mice , Thioredoxins/biosynthesis , Thioredoxins/genetics , Virulence Factors/biosynthesis , Virulence Factors/genetics
16.
Microbiol Res ; 207: 53-64, 2018 Mar.
Article En | MEDLINE | ID: mdl-29458868

Emerging antibiotic resistance among pathogenic bacteria, paired with their ability to form biofilms on medical and technical devices, represents a serious problem for effective and long-term decontamination in health-care environments and gives rise to an urgent need for new antimicrobial materials. Here we present the impact of AGXX®, a novel broad-spectrum antimicrobial surface coating consisting of micro-galvanic elements formed by silver and ruthenium, on the transcriptome of Enterococcus faecalis. A clinical E. faecalis isolate was subjected to metal stress by growing it for different periods in presence of the antimicrobial coating or silver-coated steel meshes. Subsequently, total RNA was isolated and next-generation RNA sequencing was performed to analyze variations in gene expression in presence of the antimicrobial materials with focus on known stress genes. Exposure to the antimicrobial coating had a large impact on the transcriptome of E. faecalis. After 24min almost 1/5 of the E. faecalis genome displayed differential expression. At each time-point the cop operon was strongly up-regulated, providing indirect evidence for the presence of free Ag+-ions. Moreover, exposure to the antimicrobial coating induced a broad general stress response in E. faecalis. Genes coding for the chaperones GroEL and GroES and the Clp proteases, ClpE and ClpB, were among the top up-regulated heat shock genes. Differential expression of thioredoxin, superoxide dismutase and glutathione synthetase genes indicates a high level of oxidative stress. We postulate a mechanism of action where the combination of Ag+-ions and reactive oxygen species generated by AGXX® results in a synergistic antimicrobial effect, superior to that of conventional silver coatings.


Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Enterococcus faecalis/drug effects , Gene Expression/drug effects , Oxidative Stress/drug effects , Ruthenium/pharmacology , Silver/pharmacology , Adenosine Triphosphatases/biosynthesis , Adenosine Triphosphatases/genetics , Bacterial Proteins/biosynthesis , Bacterial Proteins/genetics , Chaperonin 10/biosynthesis , Chaperonin 10/genetics , Chaperonin 60/biosynthesis , Chaperonin 60/genetics , Endopeptidase Clp/biosynthesis , Endopeptidase Clp/genetics , Glutathione Synthase/biosynthesis , Heat-Shock Proteins/biosynthesis , Heat-Shock Proteins/genetics , Microbial Sensitivity Tests , Superoxide Dismutase/biosynthesis , Thioredoxins/biosynthesis , Transcriptome/drug effects
17.
Parasit Vectors ; 11(1): 38, 2018 01 15.
Article En | MEDLINE | ID: mdl-29335000

BACKGROUND: Human babesiosis is an infectious disease that is epidemic in various regions all over the world. The predominant causative pathogen of this disease is the intra-erythrocytic parasite Babesia microti. The thioredoxin system is one of the major weapons that is used in the resistance to the reactive oxygen species (ROS) and reactive nitrogen species (RNS) produced by host immune system. In other intra-erythrocytic apicomplexans like the malaria parasite Plasmodium falciparum, anti-oxidative proteins are promising targets for the development of anti-parasitic drugs. However, to date, the sequences and biological properties of thioredoxins and thioredoxin-like molecules of B. microti remain unknown. Understanding the molecular characterization and function of B. microti thioredoxins may help to develop anti-Babesia drugs and controlling babesiosis. METHODS: The full-length B. microti thioredoxin 2 (BmTrx2) gene was obtained using a rapid amplification of cDNA ends (RACE) method, and the deduced BmTrx2 amino acid sequence was analyzed using regular bioinformatics tools. Recombinant BmTrx2 protein was expressed in vitro and purified using His-tag protein affinity chromatography resins. Reverse transcription PCR, quantitative real-time PCR and Western blot were employed to detect the expression and native proteins of BmTrx2. Indirect immunofluorescence assay was used to localize BmTrx2 in B. microti. Bovine insulin reduction assays were used to determine the enzyme activity of the purified recombinant BmTrx2 protein. RESULTS: The full-length BmTrx2 was 564 bp with a 408 bp open reading frame encoding a protein of 135 amino acids. The predicted molecular weight of the protein was 15.5 kDa. A conserved thioredoxin-like family domain was found in BmTrx2. The expression of BmTrx2 was upregulated on both the third and eighth day post-infection in mice, whereas expression was downregulated during the beginning and later stages. The results of Western blot analysis showed the native BmTrx2 in parasite lysates could be detected by mouse anti-BmTrx2 serum and that the recombinant BmTrx2 protein could be recognized by serum of B. microti-infected mice. Immunofluorescence microscopy showed that BmTrx2 localized in the cell cytoplasm of B. microti merozoites in B. microti-infected red blood cells. The results of bovine insulin reduction assay indicated the purified recombinant BmTrx2 protein possesses antioxidant enzyme activity. Dihydroartemisinin and quinine, known anti-malaria drugs, and clindamycin, a known anti-babesiosis drug, induced significantly higher upregulation of BmTrx2 mRNA. CONCLUSIONS: Our results indicate that BmTrx2 is a functional enzyme with antioxidant activity and may be involved in the response of B. microti to anti-parasite drugs.


Antiprotozoal Agents/pharmacology , Babesia microti/enzymology , Gene Expression Regulation/drug effects , Thioredoxins/biosynthesis , Thioredoxins/genetics , Animals , Blotting, Western , Cattle , Computational Biology , Fluorescent Antibody Technique, Indirect , Gene Expression Profiling , Insulin/metabolism , Mice , Oxidation-Reduction , Real-Time Polymerase Chain Reaction , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Sequence Analysis, DNA , Thioredoxins/analysis
18.
Turk Neurosurg ; 28(1): 7-12, 2018.
Article En | MEDLINE | ID: mdl-28345125

AIM: To evaluate and compare the expression of thioredoxin reductase 1 (TrxR1) in primary and secondary glioblastoma samples. MATERIAL AND METHODS: Surgically resected human glioblastoma samples from 40 patients who underwent surgery at our institution were extracted from their histopathological specimens and divided into three groups. Ten histopathologically regular cerebral tissue samples, acquired from the non-neoplastic portion of the specimens, were assigned as the control group. Twenty specimens that included tumoral tissue from each type of glioblastoma (WHO grade IV, primary and secondary) were assigned as the primary and secondary glioblastoma groups. TrxR1 expression was analyzed by using both quantitative reverse transcription polymerase chain reaction (qRT-PCR) and immunohistochemistry. Isocitrate dehydrogenase 1 (IDH1) mutation was analyzed by immunohistochemistry. Ki-67 proliferative index and apoptosis were also analyzed by immunohistochemistry. The differences between the groups were statistically compared and the correlation between these parameters was analyzed. RESULTS: The expressions of TrxR1 and Ki-67 values were significantly higher in primary glioblastoma. IDH1 mutation was significantly higher in secondary glioblastoma. TrxR1 expression was found to be highly correlated with the Ki-67 index. The apoptotic index was similar between primary and secondary glioblastoma. CONCLUSION: This study showed a high TrxR1 expression in primary glioblastoma which could indicate a role of the Trx system in promoting the malignant progression by some complex processes.


Biomarkers, Tumor/genetics , Brain Neoplasms/genetics , Disease Progression , Glioblastoma/genetics , Repressor Proteins/genetics , Thioredoxins/physiology , Adult , Aged , Biomarkers, Tumor/biosynthesis , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Female , Glioblastoma/metabolism , Glioblastoma/pathology , Humans , Isocitrate Dehydrogenase/biosynthesis , Isocitrate Dehydrogenase/genetics , Ki-67 Antigen/biosynthesis , Ki-67 Antigen/genetics , Male , Middle Aged , Mutation/physiology , Repressor Proteins/biosynthesis , Thioredoxins/biosynthesis , Thioredoxins/genetics
19.
Medicine (Baltimore) ; 96(49): e9108, 2017 Dec.
Article En | MEDLINE | ID: mdl-29245343

BACKGROUND: Coronary atherosclerotic heart disease (CAD) is mainly caused by atherosclerosis, an inflammatory disease characterized by plaque formation in arteries. Reactive oxygen species caused structural damage and dysfunction of arterial endothelial cells. Thioredoxin-interacting protein (TXNIP) is the endogenous inhibitor and regulator of thioredoxin, a major cellular antioxidant and antiapoptotic system. In order to explore the role of TXNIP in the occurrence and development of CAD, we detected the TXNIP expression and discussed its molecular mechanisms in CAD. METHODS: The mRNA levels of TXNIP gene in peripheral leucocytes were detected in CAD and healthy controls (CTR) by quantitative real-time polymerase chain reaction. And TXNIP proteins were detected by western blotting. RESULTS: TXNIP gene expression levels in patients with unstable angina pectoris (UAP, n = 96) were significantly increased compared with those of CTR (n = 192, P < .05). However, the situation is different in acute myocardial infarction (n = 96, P > .05). Logistic regression analysis showed that TXNIP levels were significantly positive correlated with UAP (OR = 1.728, P < .05). CONCLUSIONS: TXNIP gene expression in the peripheral leucocytes was increased in patients with UAP, indicating that TXNIP in circulating leucocytes may be involved in the pathogenesis of UAP.


Angina, Unstable/genetics , Myocardial Infarction/genetics , Thioredoxins/biosynthesis , Aged , Blotting, Western , Carrier Proteins , Female , Humans , Leukocytes , Lipids/blood , Male , Middle Aged , RNA, Messenger/metabolism , Real-Time Polymerase Chain Reaction
20.
FEBS Lett ; 591(20): 3414-3420, 2017 10.
Article En | MEDLINE | ID: mdl-28889641

Scorpion α-toxins are polypeptides that inhibit voltage-gated sodium channel inactivation. They are divided into mammal, insect and α-like toxins based on their relative activity toward different phyla. Several factors are currently known to influence the selectivity, which are not just particular amino acid residues but also general physical, chemical, and topological properties of toxin structural modules. The objective of this study was to change the selectivity profile of a chosen broadly active α-like toxin, BeM9 from Mesobuthus eupeus, toward mammal-selective. Based on the available information on what determines scorpion α-toxin selectivity, we designed and produced msBeM9, a BeM9 derivative, which was verified to be exclusively active toward mammalian sodium channels and, most importantly, toward the Nav 1.2 isoform expressed in the brain.


NAV1.2 Voltage-Gated Sodium Channel/chemistry , Neurotoxins/chemistry , Oocytes/drug effects , Recombinant Fusion Proteins/chemistry , Scorpion Venoms/chemistry , Amino Acid Sequence , Animals , Binding Sites , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Expression , Humans , Insecta/drug effects , Insecta/metabolism , Mice , Models, Molecular , NAV1.2 Voltage-Gated Sodium Channel/metabolism , Neurotoxins/biosynthesis , Neurotoxins/genetics , Neurotoxins/toxicity , Oocytes/cytology , Oocytes/metabolism , Protein Binding , Protein Engineering , Protein Interaction Domains and Motifs , Protein Structure, Secondary , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/toxicity , Scorpion Venoms/biosynthesis , Scorpion Venoms/genetics , Scorpion Venoms/toxicity , Scorpions/chemistry , Scorpions/pathogenicity , Sequence Alignment , Sequence Homology, Amino Acid , Structure-Activity Relationship , Substrate Specificity , Thioredoxins/biosynthesis , Thioredoxins/chemistry , Thioredoxins/genetics , Xenopus laevis
...